Skip to main content

Advertisement

Table 3 Odds ratio and 95% confidence interval for cardiometabolic risk factors: the CASPIAN-V study

From: Are non-high–density lipoprotein fractions associated with pediatric metabolic syndrome? The CASPIAN-V study

Variable Model High TC High LDL MetS Low HDL Overweight Abdominal obesity Obesity High FBS High TG High BP
OR (95%CI) OR (95%CI) OR (95%CI) OR (95%CI) OR (95%CI) OR (95%CI) OR (95%CI) OR (95%CI) OR (95%CI) OR (95%CI)
Non-HDL-C (mg/dl) Model I 1.19
(1.17,1.22)*
1.19
(1.17,1.20)*
1.01
(1.00,1.01)*
0.99
(0.99,0.99)*
1.00
(0.99,1.00)
1.00
(0.99,1.00)
1.00
(0.99,1.00)
1.00
(1.00,1.01)
1.03
(1.03,1.03)*
0.99
(0.99,1.00)
Model II 1.19
(1.16,1.22)*
1.19
(1.17,1.21)*
1.01
(1.00, 1.01)*
0.99
(0.99,0.99)*
1.00
(0.99,1.00)
1.00
(0.99,1.00)
1.00
(0.99,1.00)
1.00
(.99,1.01)
1.03
(1.02,1.03)*
0.99
(0.99,1.00)
Model III 1.19
(1.16,1.22)*
1.19
(1.17,1.21)*
1.01
(1.00, 1.01)*
0.99
(0.99,0.99)*
1.00
(.99,1.01)
1.03
(1.02,1.03)*
0.99
(0.99,1.01)
Diff-C (mg/dl) Model I 1.07
(1.06,1.08)*
1.02
(1.01,1.02)*
1.07 (1.06,1.09)* 1.04
(1.03,1.05)*
1.01
(1.00,1.02)*
1.00
(0.99,1.01)
1.00
(0.99,1.01)
1.04
(1.02,1.05)*
1.02
(1.01,1.02)*
1.00
(0.98,1.01)
Model II 1.07
(1.06,1.09)*
1.02
(1.01,1.03)*
1.08
(1.07,1.01)*
1.04
(1.04,1.05)*
1.01
(1.00,1.02)*
1.00
(0.99,1.01)
1.00
(0.99,1.01)
1.03
(1.02,1.05)*
1.03
(1.02,1.04)*
1.00
(0.99,1.01)
Model III 1.07
(1.06,1.09)*
1.02
(1.01,1.03)*
1.08
(1.07, 1.10)*
1.04
(1.04,1.05)*
1.03
(1.02,1.05)*
1.02
(1.01,1.03)*
1.00
(0.98,1.01)
Atherogenic index Model I 1.36
(1.26,1.46)*
1.02
(0.96,1.08)
1.8
(1.7, 2.00)*
2.43
(2.25,2.63)*
1.08
(1.00,1.16)*
1.00
(0.95,1.06)
1.03
(0.95,1.10)
1.29
(1.19,1.40)*
38.69
(29.85,50.14)*
1.00
(0.92,1.08)
Model II 1.34
(1.24,1.46)*
1.03
(0.96,1.10)
1.9
(1.7, 2.14)*
2.51
(2.30,2.73)*
1.07
(0.98,1.15)
1.01
(0.95,1.08)
1.03
(0.95,1.12)
1.29
(1.18,1.41)*
40.33
(30.45,53.43)*
1.02
(0.94,1.11)
Model III 1.35
(1.24,1.47)*
1.03
(0.96,1.10)
1.9
(1.8, 2.19)*
2.50
(2.30,2.72)*
1.28
(1.17,1.40)*
40.26
(30.36,53.40)*
1.00
(0.92,1.09)
  1. * Statistically significant, BP blood pressure, TG triglycerides, FBG fasting blood glucose, HDL-C high-density lipoprotein-cholesterol, TC total cholesterol, LDL-C low-density lipoprotein cholesterol;
  2. overweight: BMI; 85th–95th; obesity, BMI > 95th; low HDL: < 40 mg/dL (except in boys 15–19 y old, that cut-off was < 45 mg/dL); high LDL: > 110 mg/dL; high TG: 100 mg/dL; high TC: > 200 mg/dL; elevated FBS > 100 mg/dL; high blood pressure: > 90th (adjusted by age, sex, height); Non–HDL-C concentration was calculated by subtracting HDL-C value from total cholesterol concentration. Diff-C was defined as the difference between total amount of non-HDL cholesterol and LDL-C (Diff-C = [non-HDL-C]-[LDL-C]). Atherogenic index as the ratio between TG and HDL-C concentrations
  3. Model 1: crude model
  4. Model 2: adjusted for age, sex, living area, screen time, SES and physical activity
  5. Model3: additionally adjusted for BMI except for overweight, obesity and abdominal obesity